Contribution of mast cells to the oedema induced by Bothrops moojeni snake venom and a pharmacological assessment of the inflammatory mediators involved

Toxicon

Volumn 55, Issue 2-3, 2010, Pages 343-352

  Galvão Nascimento, Neide ^a   Sampaio, Marlos Cortez ^a   Amaral Olivo, Renata ^a   Teixeira, Catarina ^a  

^a INSTITUTO BUTANTAN   (Brazil)

Author keywords

Bothrops moojeni snake venom; Inflammatory mediators; Mast cell; Oedema

Indexed keywords

AMINOGUANIDINE; CIMETIDINE; COMPOUND 48-80; CROMOGLYCATE DISODIUM; DEXAMETHASONE; ETORICOXIB; HISTAMINE H1 RECEPTOR; HISTAMINE H2 RECEPTOR; HISTAMINE H3 RECEPTOR; HISTAMINE H4 RECEPTOR; IMATINIB; INDOMETACIN; LIPOXYGENASE; N(G) NITRO DEXTRO ARGININE METHYL ESTER; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PROMETHAZINE; PROSTAGLANDIN D2; PROSTAGLANDIN SYNTHASE; SNAKE VENOM; SNAKE VENOM ANTISERUM; THIOPERAMIDE; ZILEUTON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL GRANULE; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; HISTOPATHOLOGY; LEG EDEMA; MALE; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN DEPLETION; SNAKE;

ANIMALS; ANTIVENINS; BOTHROPS; CELL DEGRANULATION; CROTALID VENOMS; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; FOOT; FREEZE DRYING; HISTAMINE; INFLAMMATION MEDIATORS; KINETICS; LIPID METABOLISM; MALE; MAST CELLS; MICE; NITRIC OXIDE; PROSTAGLANDIN D2;

BOTHROPS MOOJENI; MUS;

EID: 72749116152     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2009.08.009     Document Type: Article

References (71)

1. Akdis C.A., and Simons F.E. Histamine receptors are hot in immunopharmacology. Eur. J. Pharmacol. 533 (2006) 69-76
2. Akin C., Brockow K., D'Ambrosio C., Kirshenbaum A.S., Ma Y., Longley B.J., and Metcalfe D.D. Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit. Exp. Hematol. 31 (2003) 686-692
3. Barbosa A.M., do Amaral R.O., Teixeira C.F., Hyslop S., and Cogo J.C. Pharmacological characterization of mouse hind paw oedema induced by Bothrops insularis (jararaca ilhoa) snake venom. Toxicon 42 (2003) 515-523
4. Bell J.K., McQueen D.S., and Rees J.L. Involvement of histamine H4 and H1 receptors in scratching induced by histamine receptor agonists in Balb C mice. Br. J. Pharmacol. 142 (2004) 374-380
5. Bonavita A.G., da Costa A.S., Pires A.L., Neves-Ferreira A.G., Perales J., Cordeiro R.S., Martins M.A., and Silva P.M. Contribution of mast cells and snake venom metalloproteinases to the hyperalgesia induced by Bothrops jararaca venom in rats. Toxicon 47 (2006) 885-893
6. Cannon K.E., Leurs R., and Hough L.B. Activation of peripheral and spinal histamine H3 receptors inhibits formalin-induced inflammation and nociception, respectively. Pharmacol., Biochem. Behav. 88 (2007) 122-129
7. Cardoso J.L., Fan H.W., França F.O., Jorge M.T., Leite R.P., Nishioka S.A., Ávila A., Sano-Martins I.S., Tomy S.C., and Santoro M.L. Randomized comparative trial of three antivenoms in the treatment of envenoming by lance-headed vipers (Bothrops jararaca) in São Paulo, Brazil. QJM 86 (1993) 315-325
8. Carvalho M., Benjamim C., Santos F., Ferreira S., and Cunha F. Effect of mast cells depletion on the failure of neutrophil migration during sepsis. Eur. J. Pharmacol. 525 (2005) 161-169
9. Chaves F., Teixeira C.F.P., and Gutiérrez J.M. Role of nitric oxide in the local and systemic pathophysiological effects induced by Bothrops asper snake venom in mice. Inflamm. Res. 55 (2006) 245-253
10. Coleman J.W. Nitric oxide: a regulator of mast cell activation and mast cell-mediated inflammation. Clin. Exp. Immunol. 129 (2002) 4-10
11. Daltry J.C., Wüster W., and Thorpe R.S. Diet and snake venom evolution. Nature 379 (1996) 537-540
12. de Araújo A.L., de Souza A.O., da Cruz-Höfling M.A., Flores C.A., and Bon C. Bothrops lanceolatus (Fer de lance) venom induces oedema formation and increases vascular permeability in the mouse hind paw. Toxicon 38 (2000) 209-221
13. de Faria L., Antunes E., Bon C., and de Araujo A.L. Pharmacological characterization of the rat paw oedema induced by Bothrops lanceolatus (Fer de lance) venom. Toxicon 39 (2001) 825-830
14. Eastmond N.C., Banks E.M., and Coleman J.W. Nitric oxide inhibits IgE-mediated degranulation of mast cells and is the principal intermediate in IFN-gamma-induced suppression of exocytosis. J. Immunol. 159 (1997) 1444-1450
15. Fox J.W., and Serrano S.M. Structural considerations of the snake venom metalloproteinases, key members of the M12 reprolysin family of metalloproteinases. Toxicon 45 (2005) 969-985
16. Galli S.J., and Tsai M. Mast cells: versatile regulators of inflammation, tissue remodeling, host defense and homeostasis. J. Dermatol. Sci. 49 (2008) 7-19
17. Gantner F., Sakai K., Tusche M.W., Cruikshank W.W., Center D.M., and Bacon K.B. Histamine H(4) and H(2) receptors control histamine-induced interleukin-16 release from human CD8(+) T cells. J. Pharmacol. Exp. Ther. 303 (2002) 300-307
18. Gilchrist M., McCauley S.D., and Befus A.D. Expression, localization, and regulation of NOS in human mast cell lines: effects on leukotriene production. Blood 10 (2004) 462-469
19. 2. Prostaglandins 35 (1988) 277-300
20. Gilfillan A.M., and Tkaczyk C. Integrated signalling pathways for mast-cell activation. Nat. Rev. Immunol. 6 (2006) 218-230
21. Guimarães A.Q., Cruz-Höfling M.A., Ferreira de Araújo P.M., Bom C., and Lôbo de Araújo A. Pharmacological and histopathological characterization of Bothrops lanceolatus (Fer de lance) venom-induced edema. Inflamm. Res. 53 (2004) 284-291
22. Gutiérrez J.M., Chaves F., Bolanos R., Cerdas L., Rojans E., Arroyo O., and Portilha E. Neutralization of local effects of venom by polyvalent antivenom. Toxicon 19 (1981) 493-500
23. Gutiérrez J.M., Ownby C.L., and Odell G.V. Pathogenesis of myonecrosis induced by crude venom and a myotoxin of Bothrops asper. Exp. Mol. Pathol. 40 (1984) 367-379
24. Gutiérrez J.M., Rojas G., Lomonte B., Gené J.A., and Cerdas L. Comparative study of the edema-forming activity of Costa Rican snake venoms and its neutralization by a polyvalent antivenom. Comp. Biochem. Physiol., C 85 (1986) 171-175
25. Gutiérrez J.M., and Lomonte B. Phospholipase A2 myotoxins from Bothrops snake venoms. Toxicon 33 (1995) 1405-1424
26. Gutiérrez J.M., Leon G., Rojas G., Lomonte B., Rucavado A., and Chaves F. Neutralization of local tissue damage induced by Bothrops asper (terciopelo) snake venom. Toxicon 36 (1998) 1529-1538
27. Guzzo M.L., Farsky S.H., De Nucci G., Antunes E., Silva M.A., and Mello S.B. Role of kinins and nitric oxide on the rabbit arthritis induced by Bothrops jararaca venom. Toxicon 38 (2000) 1535-1546
28. Hofstra C.L., Desai P.J., Thurmond R.L., and Fung-Leung W.P. Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J. Pharmacol. Exp. Ther. 305 (2003) 1212-1221
29. Horizoe T., Nagakura N., Chiba K., Shirota H., Shinoda M., Kobayashi N., Numata H., Okamoto Y., and Kobayashi S. ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor with potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model. Inflamm. Res. 47 (1998) 375-383
30. Huang J.F., and Thurmond R.L. The new biology of histamine receptors. Curr. Allergy. Asthma. Rep. 8 (2008) 21-27
31. Ishizaki M. The effects of indomethacin and verapamil on dextran-induced shock in rats. Nippon. Seirigaku. Zasshi. 47 (1985) 279-288
32. Ito S., Narumiya S., and Hayaishi O. Prostaglandin D2: a biochemical perspective. Prostaglandins Leukot. Essent. Fatty Acids 37 (1989) 219-234
33. Kanaoka Y., and Urade Y. Hematopoietic prostaglandin D synthase. Prostaglandins Leukot. Essent. Fatty Acids 69 (2003) 163-167
34. Kouyoumdjian J.A., and Polizelli C. Snake bites caused by Bothrops moojeni: report of 37 cases. Rev. Inst. Med. Trop. Sao Paulo 30 (1988) 624-632
35. Kubes P. Nitric oxide affects microvascular permeability in the intact and inflamed vasculature. Microcirculation 2 (1995) 235-244
36. Landucci E.C., Castro R.C., Pereira M.F., Cintra A.C., Giglio J.R., Marangoni S., Oliveira B., Cirino G., Antunes E., and De Nucci G. Mast cell degranulation induced by two phospholipase A2 homologues: dissociation between enzymatic and biological activities. Eur. J. Pharmacol. 343 (1998) 257-263
37. Landucci E.C., De Castro R.C., Toyama M., Giglio J.R., Marangoni S., De Nucci G., and Antunes E. Inflammatory oedema induced by the lys-49 phospholipase A(2) homologue piratoxin-i in the rat and rabbit. Effect of polyanions and p-bromophenacyl bromide. Biochem. Pharmacol. 59 (2000) 1289-1294
38. Lefer D.J., Jones S.P., Girod W.G., Baines A., Grisham M.B., and Cockrell A.S. Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice. Am. J. Physiol. 276 (1999) 1943-1950
39. Ling L.I., Whiteman M., and Moore P.K. Dexamethasone inhibits lipopolysaccharide-induced hydrogen sulfide biosynthesis in intact cells and in an animal model of endotoxic shock. J. Cell. Mol. Med. 10.1111 (2008) 1582-4934
40. Liu C., Ma X., Jiang X., Wilson S.J., Hofstra C.L., Blevitt J., Pyati J., Li X., Chai W., Carruthers N., and Lovenberg T.W. Cloning and pharmacological characterization of a fourth histamine receptor (H(4)) expressed in bone marrow. Mol. Pharmacol. 59 (2001) 420-426
41. Lomonte B. Edema-forming activity of bushmaster (Lachesis muta stenophrys) and Central American rattlesnake (Crotalus durissus durissus) venoms and neutralization by a polyvalent antivenom. Toxicon 23 (1985) 173-176
42. Lomonte B., Tarkowski A., and Hanson L.A. Host response to Bothrops asper snake venom. Analysis of oedema formation, inflammatory cells, and cytokine release in a mouse model. Inflammation 17 (1993) 93-105
43. Lovenberg T.W., Roland B.L., Wilson S.J., Jiang X., Pyati J., Huvar A., Jackson M.R., and Erlander M.G. Cloning and functional expression of the human histamine H3 receptor. Mol. Pharmacol. 55 (1999) 1101-1107
44. Majno G., Palade G.E., and Schoefl G.I. Studies on inflammation. II. The site of action of histamine and serotonin along the vascular tree: a topographic study. J. Biophys. Biochem. Cytol. 11 (1961) 607-626
45. Metcalfe D.D., Baram D., and Mekori Y.A. Mast cells. Physiol. Rev. 77 (1997) 1033-1079
46. Metz M., and Maurer M. Mast cells-key effector cells in immune responses. Trends. Immunol. 28 (2007) 234-241
47. Metz M., Piliponsky A.M., Chen C.C., Lammel V., Abrink M., Pejler G., Tsai M., and Galli S. J. Mast cells can enhance resistance to snake and honeybee venoms. Science 313 (2006) 526-530
48. Moncada S., Palmer R.M., and Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43 (1991) 109-142
49. Mota I. The mechanism of anaphylaxis. Production and biological properties of mast cell sensitizing' antibody. Immunology 7 (1964) 681-699
50. Mozdarani H., and Gharbali A. Radioprotective effects of cimetidine in mouse bone marrow cells exposed to gamma-rays as assayed by the micronucleus test. Int. J. Radiat. Biol. 64 (1993) 189-194
51. Nascimento Jr. E.B., Costa K.A., Bertollo C.M., Oliveira A.C., Rocha L.T., Souza A.L., Glória M.B., Moraes-Santos T., and Coelho M.M. Pharmacological investigation of the nociceptive response and edema induced by venom of the scorpion Tityus serrulatus. Toxicon 45 (2005) 585-593
52. Nakagawa H., Takiguchi T., Nakamura M., Furuyama A., Koyanagi S., Aramaki H., Higuchi S., and Ohdo S. Basis for dosing time-dependent change in the ant-tumor effect of imatinib in mice. J. Biochem. Pharmacol. 72 (2006) 1237-1245
53. Nautiyala K.M., Ribeirob A.C., Pfaffb D.W., Pfaffb D.W., Silver R., and Silvera R. Brain mast cells link the immune system to anxiety-like behavior. Proc. Natl. Acad. Sci. U S A 105 (2008) 18053-18057
54. Olivo R.A., Teixeira C.F., Wallace J.L., Gutierrez J.M., and Zamuner S.R. Role of cyclooxygenases in oedema-forming activity of bothropic venoms. Toxicon 49 (2007) 670-677
55. O'Reilly M., Alpert R., Jenkinson S., Gladue R.P., Foo S., Trim S., Peter B., Trevethick M., and Fidock M. Identification of a histamine H4 receptor on human eosinophils-role in eosinophil chemotaxis. J. Recept. Signal Transduct. Res. 22 (2002) 431-448
56. Ownby C.L., Gutiérrez J.M., Colberg T.R., and Odell G.V. Quantitation of myonecrosis induced by myotoxin a from prairie rattlesnake (Crotalus viridis viridis) venom. Toxicon 20 (1982) 877-885
57. Perales J., Amorim C.Z., Rocha S.L., Domont G.B., and Moussatche H. Neutralization of the oedematogenic activity of Bothrops jararaca venom on the mouse paw by an antibothropic fraction isolated from opossum (Didelphis marsupialis) serum. Agents Actions 37 (1992) 250-259
58. Picolo G., Chacur M., Gutiérrez J.M., Teixeira C.F., and Cury Y. Evaluation of antivenoms in the neutralization of hyperalgesia and edema induced by Bothrops jararaca and Bothrops asper snake venoms. Braz. J. Med. Biol. Res. 35 (2002) 1221-1228
59. Rocha J.C., Peixoto M.E., Jancar S., Cunha F.d.Q., Ribeiro R.d.A., and da Rocha F.A. Dual effect of nitric oxide in articular inflammatory pain in zymosan-induced arthritis in rats. Br. J. Pharmacol. 136 (2002) 588-596
60. Rosenfeld G. Symptomatology, pathology and treatment of snakebites in South America. In: Bucherl W., and Buckley E. (Eds). Venomous Animals And Their Venoms (1971), Academic Press, New York 345-362
61. Rucavado A., and Lomonte B. Neutralization of myonecrosis, hemorrhage, and edema induced by Bothrops asper snake venom by homologous and heterologous pre-existing antibodies in mice. Toxicon 34 (1996) 567-577
62. Salvemini D., Masini E., Anggard E., Mannaioni P.F., and Vane J. Synthesis of a nitric oxide-like factor from l-arginine by rat serosal mast cells: stimulation of guanylate cyclase and inhibition of platelet aggregation. Biochem. Biophys. Res. Commun. 169 (1990) 596-601
63. Sandler C., Joutsiniemi S., Lindstedt K.A., Juutilainen T., Kovanen P.T., and Eklund K.K. Imatinib mesylate inhibits platelet derived growth factor stimulated proliferation of rheumatoid synovial fibroblasts. Biochem. Biophys. Res. Commun. 347 (2006) 31-35
64. Tamaoki J., Nakata J., Takeyama K., Chiyotani A., and Konno K. Histamine H2 receptor-mediated airway goblet cell secretion and its modulation by histamine-degrading enzymes. J. Allergy. Clin. Immunol. 99 (1997) 233-238
65. Teixeira C.F.P., Cury Y., Oga S., and Jancar S. Hyperalgesia induced by Bothrops jararaca in rats: role of eicosanoids and platelet activating factor. Toxicon 32 (1994) 419-426
66. Teuscher C., Subramanian M., Noubade R., Gao J.F., Offner H., Zachary J.F., and Blankenhorn E.P. Central histamine H3 receptor signaling negatively regulates susceptibility to autoimmune inflammatory disease of the CNS. Proc. Natl. Acad. Sci. U S A 104 (2007) 10146-10151
67. Trebien H.A., and Calixto J.B. Pharmacological evaluation of rat paw oedema induced by Bothrops jararaca venom. Agents Actions 26 (1989) 292-300
68. Van Arman C.G., Begany A.J., Miller L.M., and Pless H.H. Some details of inflammation caused by yeast and carragenin. J. Pharmacol. Exp. Ther. 150 (1965) 328-334
69. Vane J.R. COX-2 inhibitors: background knowledge for clinical use. Introd. Inflamm. Res. 47 Suppl. 2 (1998) S77
70. Williams T.J. Interactions between prostaglandins, leukotrienes and other mediators of inflammation. Br. Med. Bull. 39 (1983) 239-242
71. Zamuner S.R., Gutiérrez J.M., Muscará M.N., Teixeira A.S., and Teixeira C.F. Bothrops asper and Bothrops jararaca snake venoms trigger microbicidal functions of peritoneal leukocytes in vivo. Toxicon 39 (2001) 1505-1513